Allergy falls squarely into the class of common disorders caused by interaction between a genetic predisposition and an environmental stimulus. Genetic approaches are revolutionising the treatment of many primary immunodeficiencies, which are caused by single gene defects, but are unlikely to be of therapeutic value in the short term for multifactorial allergic disorders such as asthma, rhinitis and eczema. Nevertheless, advances have been made in our understanding and management of these disorders, which together are among the five most common conditions for which people consult their general practitioners.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Department of Allergy, Asthma and Clinical Immunology, Alfred Hospital, Prahran, VIC.
- 1. Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999; 402 (6760 Suppl): B12-B17.
- 2. Chapman MD, Smith AM, Vailes LD, et al. Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 2000; 106: 409-418.
- 3. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000; 343: 1313-1324.
- 4. Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999; 402 (6760 Suppl): B31-B38.
- 5. Rolland JM, Douglass JA, O'Hehir RE. Allergen immunotherapy: current and new therapeutic strategies. Exp Opin Invest Drugs 2000; 9: 515-527.